In today’s clinical trials, compared to those of the past, there is increasing complexity, greater data collection, and a ...

For participants in clinical trials, the answer is a hard no. The Trump administration's decision to end funding for the U.S.

Exploring Regulatory Affairs, the discipline dedicated to ensuring that new drugs and biologics are safe, effective, and ...

A local breast cancer survivor is hoping to break down barriers when it comes to increasing diversity in medical trials.

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

Clinical research is indeed a data beast. Healthcare organizations are practically drowning in patient information from their studies—everything from vitals to lab results to patient-reported outcomes ...

Innovation, collaboration, and regulatory reform were on the agenda at the 2025 Clinical Trial Supply Europe conference.

This is due to a lack of data from large-scale clinical trials depicting the valuable effects of probiotics in improving ...